PROVIDER PROFILE · NPI 1881696003

Ryan SullivanMD

Hematology-OncologyCambridge, MAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

315

Unique beneficiaries

—

Total services

527

Distinct HCPCS

Medicare payment

$52K

Peer benchmark

Total Medicare services vs. 360 Hematology-Oncology providers in MA — below median (cohort median 624).

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$151

Distinct drugs

Brand share

0.0%

Top prescribed drugs

Prednisone23 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$2K

Payment records

By payment type

Consulting Fee$2K

Food and Beverage$62

REFERRAL NETWORK

Where Ryan Sullivan's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 10 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
THE GENERAL HOSPITAL CORPORATION	142	2,661
Amita Sharma Diagnostic Radiology · Boston, MA	18	66
Ramon Gonzalez Diagnostic Radiology · Boston, MA	15	47
Gerald Abbott Diagnostic Radiology · Boston, MA	14	50
Jeanne Ackman Diagnostic Radiology · Boston, MA	13	37
Riley Fadden Nurse Practitioner · Boston, MA	13	59
PATTI, JOHN	12	53
Yingbing Wang Diagnostic Radiology · San Francisco, CA	11	33
Matthew Gilman Diagnostic Radiology · Boston, MA	11	42
Florian Fintelmann Diagnostic Radiology · Boston, MA	11	36

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history